Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2006
09/08/2006WO2006092422A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
09/08/2006WO2006092417A1 6 -heteroaryl-1, 2, 3,4,4a, 1ob-hexahydro-phenanthridines as pde-4 inhibitors for the treatment of inflammatory disorders
09/08/2006WO2006071548A3 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases
09/08/2006WO2006029142A3 Methods and systems for treating asthma and other respiratory diseases
09/08/2006CA2600891A1 Microcrystalline ( 5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl) acetic acid
09/08/2006CA2600118A1 Fermented compositions having immunomodulatory actions
09/08/2006CA2599967A1 Kim-1 antibodies for treatment of th2-mediated conditions
09/08/2006CA2599544A1 Novel aminopyridine compound with syk inhibitory activity
09/08/2006CA2598860A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
09/08/2006CA2598858A1 6 -heteroaryl-1, 2, 3,4,4a, 1ob-hexahydro-phenanthridines as pde-4 inhibitors for the treatment of inflammatory disorders
09/07/2006US20060199865 Synergistic combination comprising roflumilast and (r,r) - formoterol
09/07/2006US20060199859 Topical medicaments and methods for photodynamic treatment of disease
09/07/2006US20060199856 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid
09/07/2006US20060199827 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
09/07/2006US20060199825 4-Aminating a 4-chloro-2-hydroxy-3-nitrodihydroquinoline with a N-(hetero)cyclylpiperazine, and alkylating the remaining amine group in the quinoline ring to produce a 4-(4-(hetero)cyclylpiperazinyl)-3-nitro-1-alkyldihydroquinolinone
09/07/2006US20060199815 NK1 antagonists
09/07/2006US20060199795 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma
09/07/2006US20060199789 medical composition
09/07/2006US20060196500 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage
09/06/2006EP1698695A2 Antisense oligonucleotides for the inhibition of expression of type I procollagen
09/06/2006EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors
09/06/2006EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions
09/06/2006EP1698375A1 Azetidine ring compounds and drugs comprising the same
09/06/2006EP1698339A1 Neutrophilia inhibitor
09/06/2006EP1698335A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates
09/06/2006EP1698334A1 Pharmaceutically active isoindoline derivatives
09/06/2006EP1697389A2 Compounds and methods for treating toll-like receptor 2-related diseases and conditions
09/06/2006EP1697360A1 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo 1, 2-a pyridine-6-carboxamide mesylate salt.
09/06/2006EP1697351A1 2,6-bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists
09/06/2006EP1697347A1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratiory syncytial virus replication
09/06/2006EP1697345A1 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
09/06/2006EP1697343A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
09/06/2006EP1697322A1 Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
09/06/2006EP1696941A1 Lactic acid producing bacteria and lung function
09/06/2006EP1696882A1 Combined doses of tiotropium and fluticasone
09/06/2006EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
09/06/2006EP1349553B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
09/06/2006EP1345607B1 Therapeutic combination of amlodipine and benazepril / benazeprilat
09/06/2006EP1173224B1 Polyethyleneimine:dna formulations for aerosol delivery
09/06/2006CN1829712A Nicotinamide derivatives useful as PDE4 inhibitors
09/06/2006CN1829695A Aminoquinoline derivatives and their use as adenosine A3 ligands
09/06/2006CN1829694A Quinoline derivates and their use in therapy
09/06/2006CN1829693A Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same
09/06/2006CN1829689A Benzylamine derivative
09/06/2006CN1829526A Soluble CLCA-1 and antagonists to CLCA-1
09/06/2006CN1829520A Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation
09/06/2006CN1829505A The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
09/06/2006CN1827638A Vancomycin and nor-vancomycin derivatives and their preparation process and use
09/06/2006CN1827152A Dispersible tablet with loquat and method for preparing the same
09/06/2006CN1827146A Health-caring food for preventing and treating acute and chronic laryngopharyngitis and method for preparing the same
09/06/2006CN1827134A Effervescence tablet for treating acute bronchitis, its preparation and quality control method
09/06/2006CN1827129A Moisture-resisting toxin-removing Chinese medicinal spray
09/06/2006CN1827126A Chinese medicinal composition for treating viral infection of upper respiratory tract and preparing process thereof
09/06/2006CN1827121A Preparation of safflower and its extract and their medical application in promoting tissue blood vessel regeneration
09/06/2006CN1827120A Pharmaceutical composition containing ginkgo leaf extract and adrenoceptor agonist
09/06/2006CN1827100A Pharmaceutical composition using ramatroban as active ingredient, its preparation method and use
09/06/2006CN1826987A Serial product containing Chinese herbal medicine and pear juice
09/06/2006CN1826956A Health-caring vermicelli with sichuan fritillary bulb
09/06/2006CN1826955A Health-caring vermicelli with beach silvertop root
09/06/2006CN1273828C Detection method for capsule for treating cold and cough
09/06/2006CN1273463C (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same
09/06/2006CN1273456C Thiazole or oxazole derivatives
09/06/2006CN1273188C Method for culturing Calmette-Guerin bacillus or inactivated Calmette-Guerin bacillus
09/06/2006CN1273179C Medicine for treating cough
09/06/2006CN1273164C Cough-stopping tablet and its preparation method
09/06/2006CN1273155C Oral Chinese medicinal preparation for treating acute pharyngolaryngitis
09/06/2006CN1273153C Chinese medicinal preparation for treating pharyngolaryngitis and its manufacturing method
09/06/2006CN1273137C Compound preparation containing Brufen arginine codeine
09/06/2006CN1273134C Soft capsule of fibrauretine and preparation method thereof
09/05/2006US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative
09/05/2006US7102009 For treating cancer and angiogenesis-related disorders
09/05/2006US7101911 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene
09/05/2006US7101882 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
09/05/2006US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor
09/05/2006US7101866 6,9-Difluoro-17 alpha -((2-furanylcarbonyl)oxy)-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; antiinflammatory agents for the treatment of allergic conditions
09/05/2006US7101856 Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
09/05/2006US7101851 IgE receptor antagonists
09/05/2006US7101559 Immunomodulatory protein and useful embodiments thereof
09/05/2006CA2393640C Pyrrolo[2,3-d]pyrimidine compounds
08/2006
08/31/2006WO2006091841A2 Compositions and their uses directed to il-4r alpha
08/31/2006WO2006091674A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases
08/31/2006WO2006091112A1 Compositions for the delivery of rna interference molecules and methods for their use
08/31/2006WO2006091033A1 Composition for reducing the exudation of serum proteins
08/31/2006WO2006090853A1 Nitrogenous heterocyclic compound and medicinal use thereof
08/31/2006WO2006090817A1 Indole compound and use thereof
08/31/2006WO2006090698A1 Kinase inhibitor and use thereof
08/31/2006WO2006090235A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
08/31/2006WO2006090150A1 Pharmaceutical composition comprising amorphous rosiglitazone
08/31/2006WO2006090127A1 Pharmaceutical formulation
08/31/2006WO2006089689A1 2-quinolone compounds as inhibitors of phosphodiesterases
08/31/2006WO2006089586A1 Use of a compound with clusterin activity for the treatment of diseases associated with the deposition of abnormal proteins
08/31/2006WO2006066924A3 Azole derivatives with antimuscarinic activity
08/31/2006WO2006027345A3 Novel 3-thia-10-aza-phenanthrene derivatives
08/31/2006US20060194951 Polynucleotides encoding interferon gamma polypeptides
08/31/2006US20060194864 Indole derivatives
08/31/2006US20060194862 respiratory, urinary and gastrointestinal systems disorders; 2-cyclopentyl-2-hydroxy-N-[(3S)-1-benzyl-pyrrolidin-3-yl]-2-phenyl acetamide; side effects reduction; compounds exhibit significant potency
08/31/2006US20060194851 Benzofuran compound and medicinal composition containing the same
08/31/2006US20060194850 methyl 3-(4-{4-[1-(2-chlorophenyl)ethoxycarbonylamino]-3-isoxazolyl}-benzylsulfanyl)propionate; compounds inhibit the physiological activity of lysophosphatidic acid (LPA); treatment of fibrosis of organs (liver, kidney, lung, and the like), hepatic disease
08/31/2006US20060194848 Substituted amine derivatives and methods of use
08/31/2006US20060194841 Benzylamine derivative